Med Ed Report briefs: June 2014

Share this article:
Med Ed Report briefs: June 2014
The Blood Sugar Basics website

The ACCME put the University of Louisville CME program on probation after discovering that a physician employed by a pharma company taught at a course in Phoenix, AZ. The move came less than two months after another med-ed committee put the school on probation, The Courier-Journal reported.

Merck launched Blood Sugar Basics to improve physician-patient dialogue around proper A1C management. The program, aimed at PCPs who have patients with type 2 diabetes, debuted at May's American Association of Clinical Endocrinologists 23rd Annual Scientific and Clinical Congress.

Despite advances in gout treatment, physician education remains the greatest unmet need in the therapeutics market, said research and consulting firm GlobalData. Most physicians “still do not take gout seriously enough,” its report says.

BroadcastMed announced enhancements, such as closed-captioning and enhanced search, to its online structured learning application. The application, open to HCPs on its network, supports learning activities sponsored by academic medical centers, medical device manufacturers and med-ed companies, the firm said.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?